Dr. Amit Singal, MD

Dr. Singal practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Singal's NPI, 1073653622, was assigned on February 6, 2007. Dr. Singal graduated from University Of Michigan Medical School in 2003. Dr. Singal holds Texas license N666.

Dr. Singal's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Singal's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Singal is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Singal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singal practices, 3 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Singal's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Singal is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Singal's licenses on file in 3 states: Texas, Michigan and Washington.

Dmand AI lists cirrhosis of the liver among the conditions Dr. Singal treats.

CMS data shows 125 Medicare services from Dr. Singal across 3 procedure codes in 2024, for 54 Medicare patients. Medicare paid $8,112 for them.

CMS counts 54 Medicare patients who saw Dr. Singal in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singal's median patient age at 64, with 46% women.

In 2024, Dr. Singal wrote 92 Medicare Part D claims for 26 patients. 84% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $15,521 in total drug cost. In 2023, CMS named 58 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Singal for performance year 2024, reported as part of a group. Dr. Singal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singal as offering telehealth.

Dmand AI links 662 papers to Dr. Singal, published from 2009 to 2025. 2021 was the busiest year, with 69. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Liver Cirrhosis. Dr. Singal has published most often in Clin Gastroenterol Hepatol. Dr. Singal's most frequent co-authors are Adam Charles Yopp, MD, Nicole Elizabeth Rich, MD and Akbar Karim Waljee, MD.

Dmand AI links Dr. Singal to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Hepatocellular, Colonic Neoplasms and Liver Neoplasms. University of Texas Southwestern Medical Center sponsors the most, 4.

CMS Open Payments shows 843 general payments to Dr. Singal from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $275,855. It also lists 3 research payments totaling $2,172 from 2021 to 2024.

Dmand AI lists 2 awards for Dr. Singal, most recently CMS Stage 1 EHR in 2011. Dr. Singal serves on Practice Guidelines Committee American Association for the Study of Liver Diseases (AASLD).

Dr. Singal graduated from University Of Michigan Medical School in 2003. Dr. Singal is a member of ACG.

Dr. Singal is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.